High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: A four year prospective longitudinal follow-up study

Journal of Psychiatric Research

Volumn 45, Issue 10, 2011, Pages 1273-1282

  Wozniak, Janet ^a,b   Petty, Carter R ^a   Schreck, Meghan ^a   Moses, Alana ^a   Faraone, Stephen V ^b,c   Biederman, Joseph ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Adolescent; Bipolar disorder; Children; Course; Follow up

Indexed keywords

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; BIPOLAR DISORDER; CHILD; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MORBIDITY; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSOCIAL CARE; SCHOOL CHILD; STRUCTURED INTERVIEW;

ADOLESCENT; AGE FACTORS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; BIPOLAR DISORDER; CHILD; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 80053101685     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.10.006     Document Type: Article

References (56)

1. Altshuler L., Gitlin M., Mintz J., Leight K., Frye M. Subsyndromal depression is associated with functional impairment in patients with bipolar disorder. Journal of Clinical Psychiatry 2002, 63:807-811.
2. Biederman J. Developmental subtypes of juvenile bipolar disorder. Harvard Review of Psychiatry 1995, 3:227-230.
3. Biederman J., Faraone S.V., Wozniak J., Mick E., Kwon A., Cayton G.A., Clark S.V. Clinical correlates of bipolar disorder in a large, referred sample of children and adolescents. Journal of Psychiatric Research 2005, 39:611-622.
4. Biederman J., Hammerness P., Doyle R., Joshi G., Aleardi M., Mick E. Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatric Disease and Treatment 2008, 4:203-207.
5. Biederman J., McDonnell M.A., Wozniak J., Spencer T., Aleardi M., Falzone R., Mick E. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectrums 2005, 10:141-148.
6. Biederman J., Mick E., Faraone S.V., Van Patten S., Burback M., Wozniak J.A. Prospective follow up study of pediatric bipolar disorder in boys with attention deficit/hyperactivity disorder. Journal of Affective Disorders 2004, 82S:S17-S23.
7. Biederman J., Mick E., Spencer T., Doyle R., Joshi G., Hammerness P., et al. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectrums 2007, 12:683-689.
8. Birmaher B., Axelson D., Goldstein B., Strober M., Gill M.K., Hunt J., et al. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. American Journal of Psychiatry 2009, 166:795-804.
9. Birmaher B., Axelson D., Strober M., Gill M.K., Valeri S., Chiappetta L., et al. Clinical course of children and adolescents with bipolar spectrum disorders. Archives of General Psychiatry 2006, 63:175-183.
10. Chang K., Adleman N.E., Dienes K., Simeonova D.I., Menon V., Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Archives of General Psychiatry 2004, 61:781-792.
11. Chang K., Barnea-Goraly N., Karchemskiy A., Simeonova D.I., Barnes P., Ketter T., Reiss A.L. Cortical magnetic resonance imaging findings in familial pediatric bipolar disorder. Biological Psychiatry 2005, 58:197-203.
12. Chang K., Karchemskiy A., Barnea-Goraly N., Garrett A., Simeonova D.I., Reiss A. Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:565-573.
13. Delbello M.P., Findling R.L., Kushner S., Wang D., Olson W.H., Capece J.A., et al. A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:539-547.
14. Delis D., Kramer J., Kaplan E., Ober B. The california verbal learning test -children's version 1994, Psychological Corporation, San Antonio.
15. Faraone S., Glatt S., Tsuang M. The genetics of pediatric onset bipolar disorder. Biological Psychiatry 2003, 53:970-977.
16. Findling R.L., Gracious B.L., McNamara N.K., Youngstrom E.A., Demeter C.A., Branicky L.A., Calabrese J.R. Rapid, continuous cycling and psychiatric co-morbidity in pediatric bipolar I disorder. Bipolar Disorders 2001, 3:202-210.
17. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV Axis I disorders-clinician Version (SCID-CV) 1997, American Psychiatric Press, Washington, DC.
18. Frye M.A., Helleman G., McElroy S.L., Altshuler L.L., Black D.O., Keck P.E., et al. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. American Journal of Psychiatry 2009, 166:164-172.
19. Geller B. Phenomenology and course of pediatric bipolar disorders 1994, Washington University School of Medicine.
20. Geller B., Cook E.H. Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles. Biological Psychiatry 2000, 47:605-609.
21. Geller B., Craney J.L., Bolhofner K., DelBello M.P., Williams M., Zimerman B. One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry 2001, 158:303-305.
22. Geller B., Craney J.L., Bolhofner K., Nickelsburg M.J., Williams M., Zimerman B. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry 2002, 159:927-933.
23. Geller B., Tillman R. Prepubertal and early adolescent bipolar I disorder: review of diagnostic validation by Robins and Guze criteria. Journal of Clinical Psychiatry 2005, 7(66 Suppl):21-28.
24. Geller B., Tillman R., Bolhofner K., Zimerman B. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Archives of General Psychiatry 2008, 65:1125-1133.
25. Geller B., Tillman R., Bolhofner K., Zimerman B., Strauss N.A., Kaufmann P. Controlled, blindly rated, direct-interview family study of a prepubertal and early-adolescent bipolar I disorder phenotype: morbid risk, age at onset, and comorbidity. Archives of General Psychiatry 2006, 63:1130-1138.
26. Geller B., Tillman R., Craney J.L., Bolhofner K. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Archives of General Psychiatry 2004, 61:459-467.
27. Geller B., Zimerman B., Williams M., Bolhofner K., Craney J.L., Delbello M.P., Soutullo C.A. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2000, 10:157-164.
28. Geller B., Zimerman B., Williams M., Delbello M.P., Bolhofner K., Craney J.L., et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. Journal of Child and Adolescent Psychopharmacology 2002, 12:11-25.
29. Golden C.J. Stroop Color and word test: a Manual for clinical and Experimental use 1978, Stoelting, Co, Chicago.
30. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Wisconsin Card Sort test Manual: Revised and Expanded 1993, Psychological Assessment Resources, Inc., Odessa, FL.
31. Hollingshead A.B. Four Factor Index of social status 1975, Yale Press, New Haven.
32. Judd L.L., Akiskal H.S., Schettler P.J., Coryell W., Endicott J., Maser J.D., et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry 2003, 60:261-269.
33. Kafantaris V., Coletti D.J., Dicker R., Padula G., Pleak R.R., Alvir J.M. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:984-993.
34. Keck P., McElroy S., Strakowski S., West S., Sax K., Hawkins J., et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. American Journal of Psychiatry 1998, 155:646-652.
35. Kessler R.C., Adler L., Barkley R., Biederman J., Conners C.K., Demler O., et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. American Journal of Psychiatry 2006, 163:716-723.
36. Leibenluft E., Rich B.A., Vinton D.T., Nelson E.E., Fromm S.J., Berghorst L.H., et al. Neural circuitry engaged during unsuccessful motor inhibition in pediatric bipolar disorder. American Journal of Psychiatry 2007, 164:52-60.
37. Lewinsohn P., Klein D., Seeley J. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:454-463.
38. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M., Petukhova M., Kessler R.C. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Archives of General Psychiatry 2007, 64:543-552.
39. Moore C.M., Biederman J., Wozniak J., Mick E., Aleardi M., Wardrop M., et al. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex. Journal of Affective Disorders 2007, 99:19-25.
40. Moos R.H., Moos B.S. Manual for the family Environment scale 1974, Consulting Psychologists Press, Palo Alto, CA.
41. Nierenberg A., Henin A., Mick E., Ostacher M., Borrelli D.J., Gironde S.V.M., et al. Relationship between comorbid psychopathology among adults with bipolar disorder and their offspring: phenotypic implications for genetic studies. Bipolar Disorders 2005, 7:82.
42. Orvaschel H. Schedule for affective disorder and schizophrenia for school-age children Epidemiologic Version 1994, Nova Southeastern University, Center for Psychological Studies, Ft. Lauderdale.
43. Pavuluri M.N., Henry D.B., Carbray J.A., Sampson G., Naylor M.W., Janicak P.G. Open label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. Journal of Affective Disorders 2004, 82:S103-S111.
44. Pavuluri M.N., O'Connor M.M., Harral E., Sweeney J.A. Affective neural circuitry during facial emotion processing in pediatric bipolar disorder. Biological Psychiatry 2007, 62:158-167.
45. Perlis R.H., Smoller J.W., Ferreira M.A., McQuillin A., Bass N., Lawrence J., et al. A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder. American Journal of Psychiatry 2009, 166:718-725.
46. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Les Archives de Psychologie 1941, 28:286-340.
47. Robins E., Guze S.B. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 1970, 126:983-987.
48. Seidman L.J., Biederman J., Weber W., Hatch M., Faraone S.V. Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biological Psychiatry 1998, 44:260-268.
49. Tohen M., Kryzhanovskaya L., Carlson G., Delbello M., Wozniak J., Kowatch R., et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. American Journal of Psychiatry 2007, 164:1547-1556.
50. Wagner K.D., Kowatch R.A., Emslie G.J., Findling R.L., Wilens T.E., McCague K., et al. A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. American Journal of Psychiatry 2006, 163:1179-1186.
51. Wagner K.D., Redden L., Kowatch R.A., Wilens T.E., Segal S., Chang K., et al. A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2009, 48:519-532.
52. Wechsler D. Manual for the Wechsler Intelligence scale for children 1991, The Psychological Corporation, Harcourt Brace Jovanovich, Inc, San Antonio. 3rd ed.
53. Wozniak J. Pediatric bipolar disorder: the new perspective on severe mood dysfunction in children. Journal of Child and Adolescent Psychopharmacology 2003, 13:449-451.
54. Wozniak J., Biederman J., Kiely K., Ablon S., Faraone S., Mundy E., Mennin D. Mania-like symptoms suggestive of childhood onset bipolar disorder in clinically referred children. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:867-876.
55. Wozniak J., Biederman J., Kwon A., Mick E., Faraone S., Orlovsky K., et al. How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biological Psychiatry 2005, 58:583-588.
56. Wozniak J., Monuteaux M., Richards J., Lail K., Faraone S.V., Biederman J. Convergence between structured diagnostic interviews and clinical assessment on the diagnosis of pediatric-onset bipolar disorder. Biological Psychiatry 2003, 53:938-944.